PRCT Q4 2021 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$10M+214.7% YoY

Gross Profit

$5M44.5% margin

Operating Income

-$17M-166.0% margin

Net Income

-$18M-181.0% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+17.0%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$337M

Total Liabilities

$70M

Stockholders' Equity

$267M

Cash & Equivalents

$304M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$3M	+214.7%
Gross Profit	$5M	$470,000	+860.9%
Operating Income	-$17M	-$13M	-27.4%
Net Income	-$18M	-$15M	-20.1%

Geographic Segments

UNITED STATES

$5M87%

Outside the United States

$768,00013%